How does the USPTO handle potential fraud discovered during supplemental examination?

The USPTO has specific procedures for handling potential fraud discovered during supplemental examination. The MPEP explains: “In accordance with 35 U.S.C. 257(e), if the Office becomes aware, during the course of a supplemental examination or ex parte reexamination ordered under 35 U.S.C. 257, that a material fraud on the Office may have been committed in…

Read More

How does the USPTO handle multiple copending reexamination proceedings?

The USPTO has specific procedures for handling multiple copending reexamination proceedings. According to MPEP 2686.01: “Where multiple copending reexamination proceedings have been filed for a patent, the Director of the USPTO may determine whether to merge all such proceedings.” The decision to merge proceedings is made on a case-by-case basis. Factors considered include: The status…

Read More

How often does the Director order reexamination on their own initiative?

According to MPEP 2239, reexamination ordered at the Director’s initiative is uncommon: “A decision to order reexamination at the Director’s initiative is, however, rare. Only in compelling circumstances, after a review of all the facts concerning the patent, would such a decision be made.” This indicates that while the Director has the authority to order…

Read More

What happens if the USPTO receives a FOIA request for confidential information in a patent term extension application?

If the United States Patent and Trademark Office (USPTO) receives a Freedom of Information Act (FOIA) request for confidential information in a patent term extension application, specific procedures are followed. According to MPEP 2760: “Should the Office receive a Freedom of Information Act (FOIA) request for the material, the applicant will be provided notice and…

Read More